| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,136,000 | 7,067,000 | 3,083,000 | 1,482,000 | | Cost of Revenue |
-
| (3,631,000) | 5,407,000 | (615,000) | | | Gross Profit | 3,136,000 | 10,698,000 | (2,324,000) | 2,097,000 | | | Operating Expenses | | Research Development |
-
| (203,000) | 203,000 |
-
| | Selling General and Administrative | 2,156,000 | 8,091,000 | (2,511,000) | 2,485,000 | | Non Recurring | 78,000 | 278,000 | 111,000 | 149,000 | | Others | 188,000 | (211,000) | 312,000 | 301,000 | | | | Total Operating Expenses |
-
| 7,955,000 | (1,885,000) |
-
| | | | Operating Income or Loss | 714,000 | 2,743,000 | (439,000) | (838,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (4,087,000) | 1,339,000 | 2,748,000 | | Earnings Before Interest And Taxes | 714,000 | (1,344,000) | 900,000 | 1,910,000 | | Interest Expense | 206,000 | (1,295,000) | 636,000 | 1,296,000 | | Income Before Tax | 508,000 | (49,000) | 264,000 | 614,000 | | Income Tax Expense | 138,000 | (135,000) | (41,000) | 312,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 370,000 | 86,000 | 305,000 | 302,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,000 | (2,000) | 7,000 | | Extraordinary Items |
-
| (26,000) |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 370,000 | 61,000 | 303,000 | 309,000 | | Preferred Stock And Other Adjustments | (48,000) | (33,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $322,000 | $28,000 | $303,000 | $309,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
